Aplodan Ingredients & Drug Interactions
by MuscleTech
What is this page for?
First and foremost: checking Aplodan against your medications. The heart of this page is the interaction checker and the full interaction report — how this product’s ingredients may interact with prescription and over-the-counter medicines you may be taking.
Around that, we add a pharmacist’s high-level view of the product as a whole — what’s inside, the evidence for its stated use, how transparent the label is, and what safety data exists — so you can see the full picture in one place. It’s educational information from our licensed clinical databases and the clinical staff at HelloPharmacist — not medical advice — and we don’t sell or endorse products. Our editorial policy
Aplodan is a dietary supplement by MuscleTech with 2 active ingredients. Its ingredients are commonly taken for diabetic nerve pain (neuropathy), blood sugar support in diabetes, antioxidant support.Based on those ingredients, 263 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are 1,2-Dithiolane-3-Pentanoic Acid. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.
Check Your Meds Against Aplodan by MuscleTech
Ask about any prescription or over-the-counter medication and we check it for interactions with Aplodan by MuscleTech — and tell you which ingredient is responsible.
AI summaries are generated from our interaction database for education only — always confirm with your pharmacist. How we use AI
Ask the Pharmacist
A licensed pharmacist will answer your question by email — free, usually within 24 hours.
Got it — thank you!
A licensed pharmacist will answer within 24 hours. Keep an eye on your email (worth checking spam, just in case).
HelloPharmacist Scorecard of Aplodan by MuscleTech
Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.
What’s inside
Low disclosure
Aplodan contains 2 active ingredients. The primary one is alpha-lipoic acid (listed as 1,2-dithiolane-3-pentanoic acid on the label—it's the same compound), a naturally occurring antioxidant that your body uses to help convert food into energy.
The second ingredient, 2-(carbamimidoyl-methyl-amino) ethoxyphosphonic acid, we have no published data on; we can't tell you what role it plays in this formula. The product also contains several inactive ingredients—binders, fillers, and a coating—including microcrystalline cellulose, dicalcium phosphate, stearic acid, croscarmellose sodium, silicon dioxide, magnesium stearate, and sucralose.
Does it work?
Insufficient evidence
Alpha-lipoic acid has possibly effective evidence for three uses: diabetic nerve pain (neuropathy), high cholesterol (hyperlipidemia), and weight management (obesity). That means some clinical studies suggest it may help, but the evidence isn't yet strong enough to call it proven.
We hold no effectiveness data on the second active ingredient, so we can't speak to what it contributes to the formula.
How safe is it?
Well-documented data
Alpha-lipoic acid is generally well tolerated in most adults. The most common side effects from oral use are headache, heartburn, nausea, and vomiting.
Some people also report dizziness or skin rash and itching. Serious side effects are rare but have been reported in case studies.
Because alpha-lipoic acid can lower blood sugar, use it under medical guidance if you're at risk for low blood sugar. The safety data advises against use during pregnancy and while breastfeeding—there isn't enough reliable information to know it's safe in those situations.
Talk with your doctor or pharmacist about personalized advice if you're pregnant, planning pregnancy, or nursing.
Meds to double-check
Moderate interaction found
Before taking this product, check with your pharmacist if you take blood thinners or antiplatelet drugs (like warfarin or aspirin)—alpha-lipoic acid may increase bleeding risk. If you're on thyroid hormone replacement, chemotherapy (alkylating agents or antitumor antibiotics), or diabetes medications, discuss this product first, as alpha-lipoic acid may affect how well they work.
The bottom line
Scorecard at a glanceFormula with limited ingredient disclosure with insufficient evidence for its stated purpose. Moderate medication interactions have been identified, and safety information is well characterized.
Aplodan might be worth considering if you have diabetic nerve pain, high cholesterol, or want to try a supplement for weight management—and you don't take blood thinners, thyroid medication, chemotherapy, or diabetes drugs. If you're on any prescription medication, especially those, check your exact drugs with our tool before you start.
Your pharmacist can walk you through whether this fits your situation.
Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI
Assessment coverage: 1 of 2 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Dec 23, 2011.
This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed
General information
Key facts about Aplodan, straight from the product label.
| Brand | MuscleTech |
|---|---|
| Barcode (UPC) | 631656601220 |
| Net contents | 63 Caplet(s) |
| Market status | On market |
| Date entered into DSLD | Dec 23, 2011 |
| DSLD ID | 3016 |
| Product type | Non-nutrient/non-botanical |
| Supplement form | Other (e.g. Tea Bag) |
| Dietary claims / uses | All Other, Structure/Function |
| Intended target group(s) | Adult (18 - 50 Years) |
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.
Supplement Facts
The label details for Aplodan by MuscleTech, sourced from the NIH Dietary Supplement Label Database.
Supplement Facts
| Ingredient | Amount | % DV |
|---|---|---|
| 1,2-Dithiolane-3-Pentanoic Acid | 0 NP | -- |
| Aplodan | 1010 mg | -- |
| 2-(Carbamimidoyl-Methyl-amino) Ethoxyphosphonic Acid | 0 NP | -- |
Other ingredients: Microcrystaline Cellulose, Dicalcium Phosphate Anhydrous, Stearic Acid, Coating, Croscarmellose Sodium, Silicon Dioxide, Magnesium Stearate, Sucralose
Tap any ingredient to jump to its full detail below.
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
Brand IP Statement(s)
The Aplodan Advantage; Unlock Muscle Size and Strengh With Aplodan, you now have in your hands the key to unlocking strength you never knew you had, and as a result, the ability to trigger more muscle growth than you ever thought possible.
2007 Covered by U.S. patent #6,136,339 and patents pending. The Aplodan trademark is owned by Aplodan Formulations Ltd. All other trademarks are owned by their respective companies and used under license.
General Statements
But to do it, you must understand the full power of Aplodan and how it takes the single greatest problem holding you back from getting as big and strong as possible - untapped dormant muscle fibers. Trigger Dormant Muscle Activation In every bundle of muscle fibers within your body, you have several clusters of muscle fibers that are dormant and don't materially function or contribute to improving muscle size. During a typical workout, you never actually stress your muscles enough to trigger growth in these dormant muscle fibers. But now, after utilizing years of research including clinical research at the University of Milan, Team MuscleTech has engineered Aplodan - the world's first and only dormant muscle fiber activator that allows you to increase muscle fiber activation by an average of 83%! It's the key to unlocking the potential for new muscle that's been locked away in your body for years! The Scientific Research Behind Aplodan Over 30 independent scientific studies have examined the multiple performance and metabolic effects of the revolutionary Aplodan complex. In just one of these studies, Aplodan was shown to increase stimulation for greater muscle fiber activation in as little as 7 days! To accurately measure the power of the Aplodan formula researchers used an isometric grip test (the widely accepted device used to measure raw power and strength). By the conclusion of the study subjects were able to achieve muscle tension thresholds that were 83% greater than baseline (1.74 vs. 3.18 mins.) proving Aplodan's potent effectiveness! In a separate battery of tests, sprinters taking Aplodan increased their speed/power by increments that would normally take years to develop! The bottom line is that Aplodan is the only supplement of its kind that gives you the ability to be strong enough in the gym to activate dormant muscle fibers! Rapid Delivery of Aplodan Designed with special rapid release technology, the Aplodan complex starts working quickly. It drives itself inside your muscle fibers affecting the internal metabolic machinery for improved muscle fiber activation. Aplodan's unique molecular structure is designed to manipulate the metabolic environment deep within muscle fibers, promoting activation, and subsequently allowing you to train with the type of intensity necessary to allow you to trigger the growth potential that lies within dormant muscle fibers. Aplodan Takes the Bodybuilding World by Storm! As a supplement with an extremely impressive history, research backing, and human clinical trials to prove its potent effects, millions of bodybuilders everywhere are now educating themselves on dormant muscle fibers and how Aplodan is the first and best way to activate them. Right on the heels of the most popular group of supplements like naNox9, GAKIC, LEUKIC, and Anator-p70, Aplodan is poised to be the biggest supplement to ever hit bodybuilding! Awaken the untapped muscular growth potential you have inside you right now and build massive size and strength the Aplodan way.
Based on Research Conducted at The University of Milan
Research and development
New!
World's 1st dormant muscle fiber activator 83% more muscle fiber activator Triggers untapped human growth potential Pharmacologically engineered to trigger dormant muscle fiber activation in 7 days Scientifically researched in over 30 independent studies
Made in the U.S.A. from international and domestic ingredients.
FDA Statement of Identity
Dietary Supplement
Suggested/Recommended/Usage/Directions
Directions: (a) for the first week: take 2 servings (2 caplets) of Aplodan, 3 times daily. (b) From the second week onwards: take 1 serving (1 caplet), 3 times a daily.
Precautions
Warning: Not intended for use by persons under 18.
Do not use if pregnant or nursing. Consult a doctor before use if you have been treated for or diagnosed with, or have a family history of any medical condition or if you are using any over the counter medication(s).
Consult a medical doctor before starting any diet or exercise program. Do not exceed recommended serving. Improper use of this product will not improve results and is not advised. Use only as directed. Do not use if imprinted seal under cap is broken.
Storage
Store in a cool, dry place (60F to 80F).
FDA Disclaimer Statement
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
General
4251US
Is this label outdated? Report a formula or label change and our pharmacy team will review it.
Aplodan by MuscleTech label
The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.
Label images are published by the NIH Dietary Supplement Label Database for the version of this product on file. Always read your actual product label.
View the full label (PDF)The Ingredients in Aplodan by MuscleTech
These are the 2 active ingredients this product is made of. Select any to open its full monograph.
Serving size1 Caplet(s) Dosage formOther (e.g. Tea Bag) Servings per container63 Amounts shown are per serving.
Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.
Aplodan
- › 1,2-Dithiolane-3-Pentanoic Acid
- › 2-(Carbamimidoyl-Methyl-amino) Ethoxyphosphonic Acid
Other (inactive) ingredients: Microcrystaline Cellulose, Dicalcium Phosphate Anhydrous, Stearic Acid, Coating, Croscarmellose Sodium, Silicon Dioxide, Magnesium Stearate, Sucralose. These complete the product’s ingredient list but are not active constituents.
Aplodan by MuscleTech Drug Interactions
HelloPharmacist Interaction Report
Aplodan by MuscleTech contains alpha-lipoic acid, which has documented interactions with several medication types.
The most serious concern is with blood thinners and antiplatelet drugs (aspirin, warfarin, clopidogrel)—alpha-lipoic acid may increase bleeding risk by thinning the blood further, a Moderate-severity interaction.
Read the full breakdown — every affected drug type, severity by severity
Alpha-lipoic acid also carries Moderate-severity theoretical concerns with chemotherapy drugs. Its antioxidant effects might reduce how well alkylating agents and antitumor antibiotics work, since these drugs depend on generating free radicals to kill cancer cells.
If you're undergoing chemotherapy, discuss this product with your oncologist before starting.
Thyroid hormone replacement (levothyroxine) is another Moderate concern—animal research suggests alpha-lipoic acid may lower how well your body converts thyroid hormone into its active form. Blood sugar medications carry a Minor-severity interaction; though most studies show alpha-lipoic acid has little real effect on glucose, the theoretical risk of low blood sugar (hypoglycemia) exists if you're on diabetes drugs.
We could not check one ingredient, 2-(carbamimidoyl-methyl-amino) ethoxyphosphonic acid, because we hold no interaction data for it. Altogether, these interactions span 262 individual medications.
Use the medication checker on this page to look up your exact prescriptions before starting.
Check your own medications below · Editorial policy · How we use AI
Want to check YOUR meds against Aplodan?
Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.
Go to the checkerIngredients driving the most interactions
Individual Drug Interactions
The ingredients in Aplodan interact with 263 drugs. Click any drug to see the details.
1 of the 2 ingredients in Aplodan interact with drugs. Each result below shows which ingredient is responsible. 1,2-Dithiolane-3-Pentanoic Acid
Metformin XrGlucophage XR
How Metformin Xr interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Metformin Xr interactionMetformin, LinagliptinJentadueto
How Metformin, Linagliptin interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Metformin, Linagliptin interactionMetformin, RosiglitazoneAvandamet
How Metformin, Rosiglitazone interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Metformin, Rosiglitazone interactionMetformin, SitagliptinJanumet, Janumet XR
How Metformin, Sitagliptin interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Metformin, Sitagliptin interactionMiglitolGlyset
How Miglitol interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Miglitol interactionMuraglitazarPargluva
How Muraglitazar interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Muraglitazar interactionNateglinideStarlix
How Nateglinide interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Nateglinide interactionPioglitazoneActos
How Pioglitazone interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Pioglitazone interactionPramlintideSymlin
How Pramlintide interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Pramlintide interactionRepaglinideGlucoNorm, Prandin
How Repaglinide interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Repaglinide interactionRosiglitazone MaleateAvandia
How Rosiglitazone Maleate interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Rosiglitazone Maleate interactionSaxagliptinOnglyza
How Saxagliptin interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Saxagliptin interactionSaxagliptin, Metformin XrKombiglyze
How Saxagliptin, Metformin Xr interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Saxagliptin, Metformin Xr interactionSemaglutideOzempic, Rybelsus, Wegovy
How Semaglutide interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Semaglutide interactionSimvastatin, SitagliptinJuvisync
How Simvastatin, Sitagliptin interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Simvastatin, Sitagliptin interactionSitagliptinJanuvia, Zituvio
How Sitagliptin interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Sitagliptin interactionSitagliptin, MetforminZituvimet
How Sitagliptin, Metformin interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Sitagliptin, Metformin interactionSotagliflozinInpefa
How Sotagliflozin interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Sotagliflozin interactionTirzepatideMounjaro, Zepbound
How Tirzepatide interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Tirzepatide interactionTobutamideMobenol
How Tobutamide interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Tobutamide interactionTolazamideTolinase
How Tolazamide interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Tolazamide interactionTolbutamideOrinase
How Tolbutamide interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Tolbutamide interactionTroglitazoneRezulin
How Troglitazone interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Troglitazone interactionVildagliptinGalvus
How Vildagliptin interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Vildagliptin interactionPioglitazone, MetforminActoPlus Met
How Pioglitazone, Metformin interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Pioglitazone, Metformin interactionRosiglitazone, GlimepirideAvandaryl
How Rosiglitazone, Glimepiride interacts with Aplodan — through 1 ingredient. Tap an ingredient for the detail:
1,2-dithiolane-3-pentanoic AcidAntidiabetes Drugs Minor
Interaction Summary
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full 1,2-dithiolane-3-pentanoic Acid + Rosiglitazone, Glimepiride interactionEach ingredient & the kinds of drugs it affects
For each ingredient in Aplodan with known interactions, here are the types of medications it can affect. Open any type for the detail — or search your exact drug in the checker above.
1,2-Dithiolane-3-Pentanoic Acid
Alkylating Agents
Theoretically, the antioxidant effects of alpha-lipoic acid might alter the effectiveness of alkylating agents.
The use of antioxidants like alpha-lipoic acid during chemotherapy is controversial. There are concerns that antioxidants could reduce the activity of chemotherapy drugs that generate free radicals. However, some researchers theorize that antioxidants might make chemotherapy more effective by reducing oxidative stress that might interfere with apoptosis (cell death) of cancer cells. More evidence is needed to determine what effect, if any, antioxidants such as alpha-lipoic acid have on chemotherapy. Advise patients to consult their oncologist before using alpha-lipoic acid.
Anticoagulant/Antiplatelet Drugs
Theoretically, alpha-lipoic acid may have antiplatelet effects and may increase the risk of bleeding if used with anticoagulant or antiplatelet drugs.
In vitro, alpha-lipoic acid inhibits platelet aggregation.
Antitumor Antibiotics
Theoretically, the antioxidant effects of alpha-lipoic acid might alter the effectiveness of antitumor antibiotics.
The use of antioxidants like alpha-lipoic acid during chemotherapy is controversial. There are concerns that antioxidants could reduce the activity of antitumor antibiotic drugs, which work by generating free radicals. However, some researchers theorize that antioxidants might make chemotherapy more effective by reducing oxidative stress that might interfere with apoptosis (cell death) of cancer cells. More evidence is needed to determine what effect, if any, antioxidants such as alpha-lipoic acid have on chemotherapy involving antitumor antibiotics. Advise patients to consult their oncologist before using alpha-lipoic acid.
Thyroid Hormone
Theoretically, alpha-lipoic acid might decrease the effects of thyroid hormone drugs.
Animal research suggests that co-administration of thyroxine with alpha-lipoic acid reduces conversion into the active T3 form.
Antidiabetes Drugs
Theoretically, taking alpha-lipoic acid with antidiabetes drugs might increase the risk of hypoglycemia.
Although some small clinical studies have suggested that alpha-lipoic acid can lower blood glucose levels, larger clinical studies in patients with diabetes have shown no clinically meaningful effect. Additionally, co-administration of single doses of alpha-lipoic acid and glyburide or acarbose did not cause detectable drug interactions in healthy volunteers.
Brand information
Manufacturer and brand details for Aplodan, from the product label.
MuscleTech
See all MuscleTech products- Name
- Iovate Health Sciences U.S.A. Inc.
- Street Address
- 3880 Jeffrey Blvd
- City
- Blasdell
- State
- NY
- ZipCode
- 14219
- Phone Number
- 1-800-246-3261
- Web Address
- www.MuscleTech.com
Aplodan by MuscleTech: Common Questions
Does Aplodan by MuscleTech interact with any medications?
How can one product interact with so many drugs?
Where does this information come from?
Can I take this if I'm on blood thinners like warfarin?
What are the most common side effects?
Can I take this while pregnant or breastfeeding?
Does alpha-lipoic acid actually lower blood sugar?
What is alpha-lipoic acid, and why is it in this product?
Is this safe to take with thyroid medication?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Not sure if Aplodan is safe with your meds?
Our pharmacists answer your medication & supplement questions — free.
Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.
The Full Monographs Behind Aplodan’s Ingredients
Every ingredient we hold a full HelloPharmacist monograph for — uses, evidence, safety, and the complete interaction list.
Sources & How We Checked
Aplodan's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.
- NIH Dietary Supplement Label Database (DSLD) — The official product label on file for this supplement.
- Natural Medicines (Therapeutic Research Center) — Evidence-graded clinical reference behind the ingredient interaction data.
Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.
The 48 references behind this product’s interaction data
Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.
Alpha-lipoic Acid 48 references
- Labriola D, Livingston R. Possible interactions between dietary antioxidants and chemotherapy. Oncology 1999;13:1003-8.
- Anon. Alpha-lipoic acid. Altern Med Rev 1998;3:308-10.
- Konrad T, Vicini P, Kusterer K, et al. Alpha-lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with Type 2 diabetes. Diabetes Care 1999;22:280-7. PubMed
- Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic peripheral neuropathy with the antioxidant alpha-lipoic acid: A 3-week, multicentre randomized controlled trial (ALADIN Study). Diabetologia 1995;38:1425-33.
- Gleiter CH, Schreeb KH, Freudenthaler S, et al. Lack of interaction between thioctic acid, glibenclamide and acarbose. Br J Clin Pharmacol 1999;48:819-25. PubMed
- Jacob S, Henriksen EJ, Tritschler HJ, et al. Improvement of insulin-stimulated glucose-disposal in type 2 diabetes after repeated parenteral administration of thioctic acid. Exp Clin Endocrinol Diabet 1996;104:284-8. PubMed
- Jacob S, Henriksen EJ, Schiemann AL, et al. Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid. Arzneimittelforschung 1995;45:872-4.
- Jacob S, Ruus P, Hermann R, et al. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled, pilot trial. Free Rad Biol Med 1999;27:309-14.
- Segermann J, Hotze A, Ulrich H, Rao GS. Effect of alpha-lipoic acid on the peripheral conversion of thyroxine to triiodothyronine and on serum lipid-, protein- and glucose levels. Arzneimittelforschung 1991;41:1294-8.
- Beitner H. Randomized, placebo controlled, double-blind study on the clinical efficacy of a cream containing 5% alpha-lipoic acid related to photoaging of facial skin. Br J Dermatol 2003;149:841-9.
- Ziegler D, Nowak H, Kempler P, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: A meta-analysis. Diabet Med 2004;21:114-21.
- Prasad KN. Rationale for using high-dose multiple dietary antioxidants as an adjunct to radiation therapy and chemotherapy. J Nutr 2004;134:3182S-3S. PubMed
- Conklin KA. Cancer chemotherapy and antioxidants. J Nutr 2004;134:3201S-3204S. PubMed
- Vincent HK, Bourguignon CM, Vincent KR, Taylor AG. Effects of alpha-lipoic acid supplementation in peripheral arterial disease: a pilot study. J Alt Complement Med 2007;13:577-84. PubMed
- Furukawa N, Miyamura N, Nishida K, et al. Possible relevance of alpha lipoic acid contained in a health supplement in a case of insulin autoimmune syndrome. Diabetes Res Clin Pract 2007;75:366-7. PubMed
- Ziegler D., Ametov A., Barinov A., Dyck P. J., Gurieva I., Low P. A., Munzel U., Yakhno N., Raz I., Novosadova M., Maus J., Samigullin, R. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Car
- Gu X. M., Zhang S. S., Wu J. C., Tang Z. Y., Lu Z. Q., Li H., Liu C., Chen L., Ning, G. [Efficacy and safety of high-dose a-lipoic acid in the treatment of diabetic polyneuropathy]. Zhonghua Yi Xue Za Zhi 2010;90(35):2473-2476.
- Porasuphatana S., Suddee S., Nartnampong A., Konsil J., Harnwong B., Santaweesuk A. Glycemic and oxidative status of patients with type 2 diabetes mellitus following oral administration of alpha-lipoic acid: a randomized double-blinded placebo-controlled
- Ansar H., Mazloom Z., Kazemi F., Hejazi N. Effect of alpha-lipoic acid on blood glucose, insulin resistance and glutathione peroxidase of type 2 diabetic patients. Saudi Med J 2011;32(6):584-588. DOI
- de Oliveira A. M., Rondó P. H., Luzia L. A., D'Abronzo F. H., Illison V. K. The effects of lipoic acid and a-tocopherol supplementation on the lipid profile and insulin sensitivity of patients with type 2 diabetes mellitus: a randomized, double-blind, pla
- Mazloom Z., Ansar H. The Effect of Alpha-Lipoic Acid on Blood Pressure in Type 2 Diabetics. Iranian Journal of Endocrinology and Metabolism 2009;11(3):245-250.
- Volchegorskii I. A., Rassokhina L. M., Koliadich M. I., Alekseev M. I. [Comparative study of alpha-lipoic acid and mexidol effects on affective status, cognitive functions and quality of life in diabetes mellitus patients]. Eksp Klin Farmakol 2011;74(11):
- Cavalcanti D. R., da Silveira F. R. Alpha lipoic acid in burning mouth syndrome--a randomized double-blind placebo-controlled trial. J Oral Pathol Med 2009;38(3):254-261. PubMed
- Koh E. H., Lee W. J., Lee S. A., Kim E. H., Cho E. H., Jeong E., Kim D. W., Kim M. S., Park J. Y., Park K. G., Lee H. J., Lee I. K., Lim S., Jang H. C., Lee K. H., Lee K. U. Effects of alpha-lipoic Acid on body weight in obese subjects. Am J Med 2011;124( PubMed
- Bergqvist-Karlsson, A., Thelin, I., and Bergendorff, O. Contact dermatitis to alpha-lipoic acid in an anti-wrinkle cream. Contact Dermatitis 2006;55(1):56-57.
- Tang, J., Wingerchuk, D. M., Crum, B. A., Rubin, D. I., and Demaerschalk, B. M. Alpha-lipoic acid may improve symptomatic diabetic polyneuropathy. Neurologist. 2007;13(3):164-167. PubMed
- Hegazy SK, Tolba OA, Mostafa TM, Eid MA, El-Afify DR. Alpha-lipoic acid improves subclinical left ventricular dysfunction in asymptomatic patients with type 1 diabetes. Rev Diabet Stud 2013;10(1):58-67. PubMed
- Huang Z, Wan X, Liu J, et al. Short-term continuous subcutaneous insulin infusion combined with insulin sensitizers rosiglitazone, metformin, or antioxidant a-lipoic acid in patients with newly diagnosed type 2 diabetes mellitus. Diabetes Technol Ther 201
- Sarezky D, Raquib AR, Dunaief JL, Kim BJ. Tolerability in the elderly population of high-dose alpha lipoic acid: a potential antioxidant therapy for the eye. Clin Ophthalmol. 2016 Sep 29;10:1899-1903. PubMed
- Boriani F, Granchi D, Roatti G, Merlini L, Sabattini T, Baldini N. Alpha-lipoic acid after median nerve decompression at the carpal tunnel: a randomized controlled trial. J Hand Surg Am. 2017 Apr;42(4):236-42. PubMed
- Karkabounas S, Papadopoulos N, Anastasiadou C, et al. Effects of a-lipoic Acid, carnosine, and thiamine supplementation in obese patients with type 2 diabetes mellitus: A randomized, double-blind study. J Med Food. 2018;21(12):1197-1203.
- Murray GL, Colombo J. (r)Alpha lipoic acid is a safe, effective pharmacologic therapy of chronic orthostatic hypotension associated with low sympathetic tone. Int J Angiol. 2019;28(3):188-193. PubMed
- Bobe G, Michels AJ, Zhang WJ, et al. A randomized controlled trial of long-term (R)-α-lipoic acid supplementation promotes weight loss in overweight or obese adults without altering baseline elevated plasma triglyceride concentrations. J Nutr. 2020:
- Passiatore M, Perna A, De-Vitis R, Taccardo G. The use of alfa-lipoic acid-R (ALA-R) in patients with mild-moderate carpal tunnel syndrome: A randomised controlled open label prospective study. Malays Orthop J. 2020;14(1):1-6. PubMed
- El-Nahas MR, Elkannishy G, Abdelhafez H, Elkhamisy ET, El-Sehrawy AA. Oral alpha lipoic acid treatment for symptomatic diabetic peripheral neuropathy: A randomized double-blinded placebo-controlled study. Endocr Metab Immune Disord Drug Targets. 2020. PubMed
- Kim BJ, Hunter A, Brucker AJ, et al. Orally administered alpha lipoic acid as a treatment for geographic atrophy: A randomized clinical trial. Ophthalmol Retina. 2020;4(9):889-898. PubMed
- Derosa G, D'Angelo A, Preti P, Maffioli P. Safety and efficacy of alpha lipoic acid during 4 years of observation: A retrospective, clinical trial in healthy subjects in primary prevention. Drug Des Devel Ther. 2020;14:5367-5374.
- Sun Y, Guan X, Wang H, et al. Randomized clinical trial of combined therapy with oral a-lipoic acid and NB-UVB for nonsegmental stable vitiligo. Dermatol Ther. 2021;34(1):e14610.
- Gilron I, Robb S, Tu D, et al. Double-blind, randomized, placebo-controlled crossover trial of alpha-lipoic acid for the treatment of fibromyalgia pain: the IMPALA trial. Pain. 2021;162(2):561-568. PubMed
- Gullo D, Evans JL, Sortino G, Goldfine ID, Vigneri R. Insulin autoimmune syndrome (Hirata Disease) in European Caucasians taking a-lipoic acid. Clin Endocrinol (Oxf). 2014;81(2):204-9.
- Yukina M, Nuralieva N, Solovyev M, Troshina E, Vasilyev E. Insulin autoimmune syndrome. Endocrinol Diabetes Metab Case Rep. 2020;2020:19-0159. PubMed
- Moffa S, Improta I, Rocchetti S, Mezza T, Giaccari A. Potential cause-effect relationship between insulin autoimmune syndrome and alpha lipoic acid: Two case reports. Nutrition. 2019;57:1-4. PubMed
- Izzo V, Greco C, Corradini D, et al. Insulin autoimmune syndrome in an Argentine woman taking a-lipoic acid: A case report and review of the literature. SAGE Open Med Case Rep. 2018;6:2050313X18819601.
- EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck D, et al. Scientific opinion on the relationship between intake of alpha-lipoic acid (thioctic acid) and the risk of insulin autoimmune syndrome. EFSA J 2021;19(6):e06577. PubMed
- Jibril AT, Jayedi A, Shab-Bidar S. Efficacy and safety of oral alpha-lipoic acid supplementation for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized trials. Endocr Connect 2022;11(10):e220322. PubMed
- Corazza M, Arlotti E, Schettini N, Pacetti L, Bianchi A, Borghi A. Allergic contact dermatitis due to a-lipoic acid in a topical over-the-counter product: A case report. Contact Dermatitis 2023.
- Velasco-Amador JP, Prados-Carmona Á, Navarro-Triviño FJ. Contact urticaria syndrome caused by alpha-lipoic acid in a master formula for vulvar lichen sclerosus. Contact Dermatitis 2023;89(2):136-137. PubMed
- Sehgal T, Ohri U, Mittal N, Attri P, Dishant F. A Case of Insulin Autoimmune Syndrome in an Indian Male Taking Alpha-Lipoic Acid. Cureus 2023;15(8):e43743. PubMed
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC